
Patricia Ann Duffy
Examiner (ID: 7333)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1806, 1648, 1802, 1645, 1818 |
| Total Applications | 1671 |
| Issued Applications | 766 |
| Pending Applications | 244 |
| Abandoned Applications | 672 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12526788
[patent_doc_number] => 10005772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Immune response modifier compositions and methods
[patent_app_type] => utility
[patent_app_number] => 12/519463
[patent_app_country] => US
[patent_app_date] => 2007-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 13653
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 463
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12519463
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/519463 | Immune response modifier compositions and methods | Dec 19, 2007 | Issued |
Array
(
[id] => 5574914
[patent_doc_number] => 20090142275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Wound Suture Capable of Identifying the Presence of Bacteria'
[patent_app_type] => utility
[patent_app_number] => 11/947296
[patent_app_country] => US
[patent_app_date] => 2007-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4741
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20090142275.pdf
[firstpage_image] =>[orig_patent_app_number] => 11947296
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/947296 | Wound Suture Capable of Identifying the Presence of Bacteria | Nov 28, 2007 | Abandoned |
Array
(
[id] => 4733779
[patent_doc_number] => 20080050758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 11/929190
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 41307
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20080050758.pdf
[firstpage_image] =>[orig_patent_app_number] => 11929190
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/929190 | SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME | Oct 29, 2007 | Abandoned |
Array
(
[id] => 4866857
[patent_doc_number] => 20080145916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'MORAXELLA CATARRHALIS OUTER MEMBRANE PROTEIN-106 POLYPEPTIDE, GENE SEQUENCE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/925586
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15753
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145916.pdf
[firstpage_image] =>[orig_patent_app_number] => 11925586
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/925586 | MORAXELLA CATARRHALIS OUTER MEMBRANE PROTEIN-106 POLYPEPTIDE, GENE SEQUENCE AND USES THEREOF | Oct 25, 2007 | Abandoned |
Array
(
[id] => 81272
[patent_doc_number] => 07745175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-29
[patent_title] => 'Polynucleotides encoding Clostridium perfringens alpha toxin proteins'
[patent_app_type] => utility
[patent_app_number] => 11/925300
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 19
[patent_no_of_words] => 17623
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/745/07745175.pdf
[firstpage_image] =>[orig_patent_app_number] => 11925300
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/925300 | Polynucleotides encoding Clostridium perfringens alpha toxin proteins | Oct 25, 2007 | Issued |
Array
(
[id] => 5452191
[patent_doc_number] => 20090068228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'METHOD OF SEPARATING PROTECTIVE COMPONENTS OF BORDETELLA PERTUSSIS'
[patent_app_type] => utility
[patent_app_number] => 11/877789
[patent_app_country] => US
[patent_app_date] => 2007-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9147
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20090068228.pdf
[firstpage_image] =>[orig_patent_app_number] => 11877789
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/877789 | METHOD OF SEPARATING PROTECTIVE COMPONENTS OF BORDETELLA PERTUSSIS | Oct 23, 2007 | Abandoned |
Array
(
[id] => 9153156
[patent_doc_number] => 08586057
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-19
[patent_title] => 'Enterohemorrhagic Escherichia coli vaccine'
[patent_app_type] => utility
[patent_app_number] => 11/876655
[patent_app_country] => US
[patent_app_date] => 2007-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 13307
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11876655
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/876655 | Enterohemorrhagic Escherichia coli vaccine | Oct 21, 2007 | Issued |
Array
(
[id] => 5452193
[patent_doc_number] => 20090068230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'ENTEROHEMORRHAGIC ESCHERICHIA COLI VACCINE'
[patent_app_type] => utility
[patent_app_number] => 11/876671
[patent_app_country] => US
[patent_app_date] => 2007-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13275
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20090068230.pdf
[firstpage_image] =>[orig_patent_app_number] => 11876671
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/876671 | ENTEROHEMORRHAGIC ESCHERICHIA COLI VACCINE | Oct 21, 2007 | Abandoned |
Array
(
[id] => 4938794
[patent_doc_number] => 20080076113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Methods for identifying and monitoring patients at risk for systemic inflammatory conditions, methods for selecting treatments for these patients and apparatus for use in these methods'
[patent_app_type] => utility
[patent_app_number] => 11/867874
[patent_app_country] => US
[patent_app_date] => 2007-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18069
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076113.pdf
[firstpage_image] =>[orig_patent_app_number] => 11867874
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/867874 | Methods for identifying and monitoring patients at risk for systemic inflammatory conditions, methods for selecting treatments for these patients and apparatus for use in these methods | Oct 4, 2007 | Abandoned |
| 11/665522 | Use Of Baff To Treat Sepsis | Oct 2, 2007 | Abandoned |
Array
(
[id] => 5296002
[patent_doc_number] => 20090010928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Anti-anthrax antibody, formulations thereof, and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/904882
[patent_app_country] => US
[patent_app_date] => 2007-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15420
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20090010928.pdf
[firstpage_image] =>[orig_patent_app_number] => 11904882
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/904882 | Antibodies that bind B. anthracis exotoxin, formulations thereof, and methods of use | Sep 27, 2007 | Issued |
Array
(
[id] => 4711705
[patent_doc_number] => 20080300231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Antibacterial amide macrocycles VI'
[patent_app_type] => utility
[patent_app_number] => 11/904550
[patent_app_country] => US
[patent_app_date] => 2007-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13639
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20080300231.pdf
[firstpage_image] =>[orig_patent_app_number] => 11904550
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/904550 | Antibacterial amide macrocycles VI | Sep 25, 2007 | Abandoned |
Array
(
[id] => 4845864
[patent_doc_number] => 20080182272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'RAPID RESUSCITATION, GROWTH, CAPTURE AND DETECTION OF MICROORGANISMS'
[patent_app_type] => utility
[patent_app_number] => 11/860442
[patent_app_country] => US
[patent_app_date] => 2007-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4622
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20080182272.pdf
[firstpage_image] =>[orig_patent_app_number] => 11860442
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/860442 | Rapid resuscitation, growth, capture and detection of microorganisms | Sep 23, 2007 | Issued |
Array
(
[id] => 10381927
[patent_doc_number] => 20150266934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'METHODS FOR PROTECTION AGAINST LETHAL INFECTION WITH BACILLUS ANTHRACIS'
[patent_app_type] => utility
[patent_app_number] => 11/842438
[patent_app_country] => US
[patent_app_date] => 2007-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7565
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11842438
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/842438 | METHODS FOR PROTECTION AGAINST LETHAL INFECTION WITH BACILLUS ANTHRACIS | Aug 20, 2007 | Abandoned |
Array
(
[id] => 4820463
[patent_doc_number] => 20080226641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Outer surface proteins, their genes, and their use'
[patent_app_type] => utility
[patent_app_number] => 11/892013
[patent_app_country] => US
[patent_app_date] => 2007-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2831
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226641.pdf
[firstpage_image] =>[orig_patent_app_number] => 11892013
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/892013 | Outer surface proteins, their genes, and their use | Aug 16, 2007 | Abandoned |
Array
(
[id] => 4669798
[patent_doc_number] => 20080044858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'METHODS FOR PRODUCING BIOLOGICAL SUBSTANCES IN ENZYME-DEFICIENT MUTANTS OF ASPERGILLUS NIGER'
[patent_app_type] => utility
[patent_app_number] => 11/837279
[patent_app_country] => US
[patent_app_date] => 2007-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17596
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20080044858.pdf
[firstpage_image] =>[orig_patent_app_number] => 11837279
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/837279 | Methods for producing biological substances in enzyme-deficient mutants of Aspergillus niger | Aug 9, 2007 | Issued |
Array
(
[id] => 152181
[patent_doc_number] => 07678883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-16
[patent_title] => 'Solubility tags for the expression and purification of bioactive peptides'
[patent_app_type] => utility
[patent_app_number] => 11/782836
[patent_app_country] => US
[patent_app_date] => 2007-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 18849
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/678/07678883.pdf
[firstpage_image] =>[orig_patent_app_number] => 11782836
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/782836 | Solubility tags for the expression and purification of bioactive peptides | Jul 24, 2007 | Issued |
Array
(
[id] => 5391221
[patent_doc_number] => 20090208534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'ATTENUATED SALMONELLA AS A DELIVERY SYSTEM FOR SIRNA-BASED TUMOR THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/374916
[patent_app_country] => US
[patent_app_date] => 2007-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13972
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208534.pdf
[firstpage_image] =>[orig_patent_app_number] => 12374916
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/374916 | ATTENUATED SALMONELLA AS A DELIVERY SYSTEM FOR SIRNA-BASED TUMOR THERAPY | Jul 23, 2007 | Abandoned |
Array
(
[id] => 4820589
[patent_doc_number] => 20080226679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Novel surface exposed proteins from chlamydia pneumoniae'
[patent_app_type] => utility
[patent_app_number] => 11/826125
[patent_app_country] => US
[patent_app_date] => 2007-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 10898
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226679.pdf
[firstpage_image] =>[orig_patent_app_number] => 11826125
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/826125 | Novel surface exposed proteins from chlamydia pneumoniae | Jul 11, 2007 | Abandoned |
Array
(
[id] => 5480136
[patent_doc_number] => 20090203093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Protein Targeting To Lipid Bodies'
[patent_app_type] => utility
[patent_app_number] => 12/307690
[patent_app_country] => US
[patent_app_date] => 2007-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 19647
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203093.pdf
[firstpage_image] =>[orig_patent_app_number] => 12307690
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/307690 | Protein Targeting To Lipid Bodies | Jul 9, 2007 | Abandoned |